π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This is a prospective, multicenter, single-arm clinical study to evaluate t...
Status
Terminated
Location
Icon Eye Care
Start Date
2020-04-29
Trial ID
NCT04072016
Treatments Being Tested
This study will quantify the intraocular pressure elevation in the immediat...
Status
Completed
Location
Retina Support Services, Inc
Start Date
2007-01
Trial ID
NCT00417703
The purpose of this study was to determine the incremental intraocular pres...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-09-21
Trial ID
NCT03150160
The purpose of this study is to demonstrate superior intraocular pressure (...
Status
Completed
Location
Multiple Locations
Start Date
2013-12
Trial ID
NCT02003391
Mastocytosis is a rare condition characterized by an accumulation of mast c...
Status
Completed
Location
Masson Regnault
Start Date
2021-07-30
Trial ID
NCT04978740
Treatments Being Tested
OZURDEX endophthalmitis is a rare and potentially very serious pathology. D...
Status
Unknown
Location
CHU Saint Etienne
Start Date
2023-06-05
Trial ID
NCT06268561
The aim of this study was to evaluate structural and functional improvement...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT02600403
Treatments Being Tested
Clonidine, an agonist for alfa2 pre-synaptic, has been shown to be an effec...
Status
Unknown
Location
Federal University of Sao Paulo
Start Date
2011-07
Trial ID
NCT01677351
The main aim of this study is to holistically assess the cardiovascular and...
Status
Recruiting
Location
Dr. C.I. Parhon Hospital in Iasi
Start Date
2025-01-08
Trial ID
NCT07237451
1. The purpose of this study is to evaluate the nGoggle's accuracy and repe...
Status
Unknown
Location
Duke University Eye Center
Start Date
2019-02-11
Trial ID
NCT03760055
Treatments Being Tested